{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:12:58Z","timestamp":1793077978853,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clml.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:51:47Z","timestamp":1741881107000},"page":"e553-e562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2305-3721","authenticated-orcid":false,"given":"Nouman","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6105-367X","authenticated-orcid":false,"given":"Muzamil","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Huraira Bin","family":"Gulzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4273-0827","authenticated-orcid":false,"given":"Shree","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4664-591X","authenticated-orcid":false,"given":"Asad Ali Ahmed","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1262-0252","authenticated-orcid":false,"given":"Mirza Ammar","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7905-4133","authenticated-orcid":false,"given":"Fatima","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9793-2248","authenticated-orcid":false,"given":"Abraham","family":"Titus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-0699","authenticated-orcid":false,"given":"Amar","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7439","authenticated-orcid":false,"given":"Faiz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clml.2025.03.006_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.clml.2025.03.006_bib0002","unstructured":"Leukemia - Cancer Stat Facts. SEER. Accessed December 31, 2024. https:\/\/seer.cancer.gov\/statfacts\/html\/leuks.html."},{"key":"10.1016\/j.clml.2025.03.006_bib0003","unstructured":"American Cancer Society. 2023. Annual cancer facts & figures Accessed December 31, 2024. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures.html."},{"key":"10.1016\/j.clml.2025.03.006_bib0004","unstructured":"Research Areas - Cancer Disparities - NCI. 2015. Accessed December 31, 2024. https:\/\/www.cancer.gov\/research\/areas\/disparities."},{"issue":"4","key":"10.1016\/j.clml.2025.03.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035675","article-title":"Clonal hematopoiesis and premalignant diseases","volume":"10","author":"Kaner","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1\u20132","key":"10.1016\/j.clml.2025.03.006_bib0006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2009.10.009","article-title":"The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms","volume":"184","author":"Vardiman","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.clml.2025.03.006_bib0007","article-title":"Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators","author":"Bonilla","year":"2024","journal-title":"bioRxiv"},{"issue":"1\u20136","key":"10.1016\/j.clml.2025.03.006_bib0008","first-page":"341","article-title":"Pathogenesis of early leukemia and lymphoma","volume":"9","author":"Zhao","year":"2010","journal-title":"Cancer Biomark"},{"issue":"3","key":"10.1016\/j.clml.2025.03.006_bib0009","first-page":"364","article-title":"The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias","volume":"82","author":"Lo Coco","year":"1997","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.clml.2025.03.006_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00062752-200107000-00001","article-title":"Hematologic malignancies","volume":"8","author":"Gilliland","year":"2001","journal-title":"Curr Opin Hematol"},{"issue":"4 Suppl 3","key":"10.1016\/j.clml.2025.03.006_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/shem.2002.36921","article-title":"Molecular genetics of human leukemias: new insights into therapy","volume":"39","author":"Gilliland","year":"2002","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.clml.2025.03.006_bib0012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.clml.2025.03.006_bib0013","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2025.03.006_bib0014","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/leu.2008.30","article-title":"MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications","volume":"22","author":"Fabbri","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clml.2025.03.006_bib0015","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MOH.0b013e328303e15d","article-title":"MicroRNAs in normal and malignant hematopoiesis","volume":"15","author":"Garzon","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"6586","key":"10.1016\/j.clml.2025.03.006_bib0016","doi-asserted-by":"crossref","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","article-title":"Early detection of cancer","volume":"375","author":"Crosby","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.clml.2025.03.006_bib0017","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11899-019-00543-7","article-title":"Molecular mechanisms of resistance to tyrosine kinase inhibitors","volume":"14","author":"Yaghmaie","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"issue":"11","key":"10.1016\/j.clml.2025.03.006_bib0018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41408-022-00756-9","article-title":"Chronic lymphocytic leukemia treatment algorithm 2022","volume":"12","author":"Hampel","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2025.03.006_bib0019","doi-asserted-by":"crossref","unstructured":"Bureau UC. 2024. Older population and aging. Census.gov. Accessed December 31, 2024. https:\/\/www.census.gov\/topics\/population\/older-aging.html.","DOI":"10.4324\/9781003586524-3"},{"issue":"7","key":"10.1016\/j.clml.2025.03.006_bib0020","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jnci\/djac030","article-title":"Rural\u2013urban disparities in cancer outcomes: opportunities for future research","volume":"114","author":"Bhatia","year":"2022","journal-title":"J Nat Cancer Inst"},{"issue":"10","key":"10.1016\/j.clml.2025.03.006_bib0021","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1158\/1055-9965.EPI-05-0363","article-title":"Positive association of farm or rural residence with acute myeloid leukemia incidence in a cohort of older women","volume":"14","author":"Sinner","year":"2005","journal-title":"Cancer Epidemiol, Biomark Prevent"},{"key":"10.1016\/j.clml.2025.03.006_bib0022","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.envres.2014.05.028","article-title":"Farm residence and lymphohematopoietic cancers in the Iowa Women[U+05F3]s Health Study","volume":"133","author":"Jones","year":"2014","journal-title":"Environ Res"},{"key":"10.1016\/j.clml.2025.03.006_bib0023","unstructured":"Home. NCCS - National Coalition for Cancer Survivorship. 2024. Accessed December 31, 2024. https:\/\/canceradvocacy.org\/home\/."},{"issue":"8","key":"10.1016\/j.clml.2025.03.006_bib0024","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/ijerph21080981","article-title":"Leukemia incidence by occupation and industry: a cohort study of 2.3 million workers from Ontario, Canada","volume":"21","author":"Samsel","year":"2024","journal-title":"IJERPH"},{"issue":"4","key":"10.1016\/j.clml.2025.03.006_bib0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.shaw.2023.10.010","article-title":"Case-control study of occupational acute myeloid leukemia in the Republic of Korea","volume":"14","author":"Park","year":"2023","journal-title":"Safety Health Work"},{"issue":"21","key":"10.1016\/j.clml.2025.03.006_bib0026","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1182\/blood.V124.21.3696.3696","article-title":"Improvements in the early death rate in younger acute myeloid leukemia patients following initial therapy: a SEER database analysis","volume":"124","author":"Percival","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2025.03.006_bib0027","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41375-018-0314-7","article-title":"Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality","volume":"33","author":"Reedijk","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2025.03.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720903531","article-title":"Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population","volume":"11","author":"Carobolante","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"19","key":"10.1016\/j.clml.2025.03.006_bib0029","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2023023568","article-title":"Management of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2025.03.006_bib0030","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3324\/haematol.2023.284228","article-title":"A pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China","volume":"109","author":"Gong","year":"2024","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.clml.2025.03.006_bib0031","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11899-018-0449-7","article-title":"Tyrosine kinase inhibitors in the treatment of chronic-phase CML: strategies for frontline decision-making","volume":"13","author":"Kennedy","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"10.1016\/j.clml.2025.03.006_bib0032","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.clml.2025.03.006_bib0033","first-page":"1674","article-title":"Managing acute myeloid leukemia in the elderly","volume":"20","author":"Melchert","year":"2006","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.clml.2025.03.006_bib0034","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/annonc\/mdw547","article-title":"Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force","volume":"28","author":"Stauder","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clml.2025.03.006_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.161.2.277","article-title":"Problems with proper completion and accuracy of the cause-of-death statement","volume":"161","author":"Sehdev","year":"2001","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.clml.2025.03.006_bib0036","first-page":"249","article-title":"Errors in death certificate completion in a teaching hospital","volume":"16","author":"Jordan","year":"1993","journal-title":"Clin Invest Med"},{"issue":"4","key":"10.1016\/j.clml.2025.03.006_bib0037","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1753-6405.1992.tb00092.x","article-title":"Death certification in Western Australia\u2014classification of major errors in certificate completion","volume":"16","author":"Weeramanthri","year":"1992","journal-title":"Aust J Public Health"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:25:08Z","timestamp":1754429108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2152265025000965"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.03.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}